No black box warning on record for Panhematin

As of the latest FDA labeling reviewed, Panhematin (HEMIN) does not carry a black box warning. Standard warnings and precautions still apply — see the full Panhematin medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Phlebitis is possible. Utilize a large arm vein or a central venous catheter for administration to minimize the risk of phlebitis. ( 5.1 ) • Elevated iron and serum ferritin may occur. Monitor iron and serum ferritin in patients receiving multiple administrations of PANHEMATIN. ( 5.2 ) • PANHEMATIN has transient and mild anticoagulant effect. Avoid concurrent anticoagu

No black box warning on record for Panhematin

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Phlebitis is possible. Utilize a large arm vein or a central venous catheter for administration to minimize the risk of phlebitis. ( 5.1 ) • Elevated iron and serum ferritin may occur. Monitor iron and serum ferritin in patients receiving multiple administrations of PANHEMATIN. ( 5.2 ) • PANHEMATIN has transient and mild anticoagulant effect. Avoid concurrent anticoagu

Panhematin Black Box Warning

No black box warning on record for Panhematin

Other warnings & precautions

Panhematin Black Box Warning

No black box warning on record for Panhematin

Other warnings & precautions